Surgery Partners is trading at $14.68 (+5.69%) on September 1, 2026, as healthcare stocks outperform despite broader-market weakness.
- Healthcare is up 1.26%, supported by strong Medtronic earnings and positive GSK vaccine news.
- No new company-specific announcement or filing has been identified; the latest earnings filing dates to August 10, 2026.
- The move is best attributed to sector strength rather than a fresh company catalyst.